MSB 2.17% $1.13 mesoblast limited

Very encouraging results, albeit very small scale safety trial -...

  1. 693 Posts.
    lightbulb Created with Sketch. 266
    Very encouraging results, albeit very small scale safety trial - but if replicated in a larger trial would be very positive.

    I do note that the median age for the treated group is about double that in the control group (17.9 months vs 9.0 months). Potential confounder - I would expect older babies with a larger heart would more likely to progress to complete BiV.

    Notwithstanding that, the 3-D echocardiographic LVEDV data (indexed to body surface area) are impressive, especially at the 3 week mark (an effect not seen though in the MRI analysis).

    Some interesting and perhaps confusing stuff as you drill down in the data, highlighting the need identified by the authors for more trials. I'm sure the data from this study will assist in designing a larger trial.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.